Arca
Skip to content
Tools
Tools

Bond Biosciences, Inc.

5 private offerings reported to the SEC on Form D since 2016, $24.1M sold in all. Other health care, Missouri.

  • Form D offerings: 5
  • Reported sold: $24.1M
  • Newest: Apr 8, 2026

Every Form D offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Apr 8, 2026—$7.6M$15.0MBond Biosciences, Inc.Other health care · MissouriOct 5, 20260001014108-26-000021
Sep 6, 2024—$4.5M$4.5MBond Biosciences, Inc.Other health care · MissouriJan 29, 20260001014108-24-000040
Jan 3, 2022—$6.8M$10.0MBond Biosciences, Inc.Other health care · New YorkNot amended0001014108-21-000224
Nov 4, 2020—$5.0M$6.0MBond Biosciences, Inc.Other health care · New YorkDec 8, 20200001014108-20-000122
Sep 14, 2020—$200K$200KBond Biosciences, Inc.Other health care · New YorkNot amended0001014108-20-000108

SEC Profile

From the company's EDGAR record
Business address
New York, NY
Incorporated in
Delaware
All SEC filings
CIK 1824224 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.